Stent procedure plus drug treatment versus drugs alone
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether a catheter-based procedure (angioplasty and stenting guided by blood-flow measurements) plus medications works better than medications alone. It’s for people who recently had a TIA or stroke caused by a severe narrowing in certain brain arteries.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 30 and 80 years old.
- You had a TIA or stroke from a 70%–99% narrowing in a major brain artery within the last 3 months.
- Only one specific artery narrowing is targeted, and it’s confirmed on angiography (X-ray with dye).
- Your neurologic function is mild: modified Rankin Scale score of 0–2 before enrollment.
- You have at least one risk factor such as high blood pressure, diabetes, high cholesterol, smoking history, or heart disease.
- You can safely and reliably return for all follow-up visits and understand the study enough to consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether placing a stent in a severely narrowed brain artery, along with aggressive medication, can prevent another stroke better than medication alone. It is for people who had a mild stroke within the last 30 days due to a 70-99% blockage in a major brain artery.
This trial tests whether placing a small mesh tube (stent) in a narrowed brain artery can prevent more strokes in people who have already had a stroke despite medical treatment. It is for those with significant narrowing (70-99%) and who have had a recent stroke.
This trial studies whether an intracranial stent (a small mesh tube placed inside the brain artery) improves outcomes and safety for people with severe, symptomatic narrowing of brain arteries. It may help if symptoms continue despite antiplatelet medicine or if blood flow to the brain is poor.
This trial is testing an interventional treatment for people who have severe narrowing (70-99%) in a major brain artery that has caused a stroke or mini-stroke in the past year. The goal is to see if this treatment can help prevent future strokes.
This study compares a drug-coated stent placed in a neck (vertebral) artery versus best medical treatment with medicines and risk-factor control. It aims to reduce problems caused by a badly narrowed artery after recent stroke-like symptoms.
This pilot study tests a catheter treatment called a drug-coated balloon to treat repeat narrowing inside a previously placed brain stent. It may help people whose stent has narrowed again and is causing reduced blood flow or stroke/TIA symptoms despite best medical therapy.
Hear when a new ICAS - Intracranial Atherosclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.